Professional Overview
Maria Figueredo is a seasoned professional currently serving as Market Access and HEOR Manager Immunology at AbbVie in Montreal, Quebec, Canada. Her key expertise areas include market access, health economics, and outcomes research (HEOR), with a strong industry focus on immunology.
Experience Summary
Current Role
As the Market Access and HEOR Manager Immunology, Maria is responsible for developing and implementing market access strategies, conducting health economic and outcomes research, and collaborating with cross-functional teams to drive business outcomes. Her current position involves working closely with stakeholders to ensure successful product launches and ongoing market access.
Career Progression
Maria's career trajectory showcases progressive growth and diverse experience. Notable previous roles include Operations Manager - MBA Internship at Pampa, Operations Coordinator at Bright Star Group (BSBC S.A), and Product Manager at Empresas Carozzi S.A. These roles have contributed to her expertise in operations management, product management, and market access.
Areas of Expertise
Maria's areas of expertise include:
- Industry-specific skills: Market access, HEOR, and immunology
- Technical competencies: Operations management, product management, and project coordination
- Leadership and management capabilities: Team collaboration, stakeholder engagement, and strategic planning
Professional Impact
Although specific details on notable projects, industry contributions, and measurable achievements are not available, Maria's current role and past experiences suggest a strong ability to drive business outcomes and contribute to industry growth.
Conclusion
Maria Figueredo's professional trajectory demonstrates consistent growth, a strong focus on market access and HEOR, and significant contributions to the immunology industry. Her current role at AbbVie underscores her expertise and commitment to the field. With a value proposition centered on strategic market access planning, health economics, and outcomes research, Maria is poised to continue making impactful contributions to the immunology sector.
